Ourania Tsitsilonis

3.6k total citations · 1 hit paper
132 papers, 2.4k citations indexed

About

Ourania Tsitsilonis is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Ourania Tsitsilonis has authored 132 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 43 papers in Immunology and 32 papers in Oncology. Recurrent topics in Ourania Tsitsilonis's work include Multiple Myeloma Research and Treatments (25 papers), Immune Cell Function and Interaction (21 papers) and Immunotherapy and Immune Responses (18 papers). Ourania Tsitsilonis is often cited by papers focused on Multiple Myeloma Research and Treatments (25 papers), Immune Cell Function and Interaction (21 papers) and Immunotherapy and Immune Responses (18 papers). Ourania Tsitsilonis collaborates with scholars based in Greece, Germany and United States. Ourania Tsitsilonis's co-authors include Pinelopi Samara, Meletios Α. Dimopoulos, Evangelos Terpos, Constantin N. Baxevanis, Ioannis F. Voutsas, Michael Papamichail, Ioannis P. Trougakos, Nikos E. Papaioannou, Angelos D. Gritzapis and Marinos Tsiatas and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ourania Tsitsilonis

120 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications

2021 182 citations Evangelos Terpos, Ourania Tsitsilonis et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ourania Tsitsilonis Greece	26	880	855	685	211	207	132	2.4k
Andreas Pahl Germany	32	1.2k 1.4×	850 1.0×	591 0.9×	125 0.6×	180 0.9×	105	3.5k
Liang Ye China	24	647 0.7×	811 0.9×	353 0.5×	230 1.1×	86 0.4×	77	2.4k
William J. McKinstry Australia	26	1.3k 1.5×	665 0.8×	432 0.6×	175 0.8×	179 0.9×	54	3.0k
Andrea Fattorossi Italy	33	1.1k 1.2×	1.0k 1.2×	740 1.1×	291 1.4×	183 0.9×	141	3.5k
Doug Redelman United States	31	805 0.9×	1.2k 1.4×	484 0.7×	86 0.4×	156 0.8×	103	3.1k
Koen Vandenbroeck Spain	30	856 1.0×	1.2k 1.4×	462 0.7×	71 0.3×	115 0.6×	96	2.9k
Shikhar Mehrotra United States	36	1.2k 1.4×	1.9k 2.2×	1.2k 1.7×	81 0.4×	151 0.7×	105	3.8k
Hiroshi Suemizu Japan	33	1.6k 1.8×	685 0.8×	828 1.2×	119 0.6×	167 0.8×	198	4.0k
Wenli Liu China	33	1.5k 1.7×	683 0.8×	353 0.5×	165 0.8×	321 1.6×	168	3.2k
Angelita Rebollo France	34	1.9k 2.1×	938 1.1×	529 0.8×	105 0.5×	146 0.7×	109	3.5k

Countries citing papers authored by Ourania Tsitsilonis

Since Specialization

Citations

This map shows the geographic impact of Ourania Tsitsilonis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ourania Tsitsilonis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ourania Tsitsilonis more than expected).

Fields of papers citing papers by Ourania Tsitsilonis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ourania Tsitsilonis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ourania Tsitsilonis. The network helps show where Ourania Tsitsilonis may publish in the future.

Co-authorship network of co-authors of Ourania Tsitsilonis

This figure shows the co-authorship network connecting the top 25 collaborators of Ourania Tsitsilonis. A scholar is included among the top collaborators of Ourania Tsitsilonis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ourania Tsitsilonis. Ourania Tsitsilonis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lygirou, Vasiliki, Manousos Makridakis, George M. Spyrou, et al.. (2025). Proteomic Analysis of Bone Marrow CD138+ Cells to Identify Proteins Associated With the Response of Multiple Myeloma Patients to Commonly Used Therapeutic Regimens. PROTEOMICS. 25(16). 48–60. 1 indexed citations

Samiotaki, Martina, et al.. (2025). ERAP1 Allotypes 2 and 10 Differentially Regulate the Immunopeptidome of Melanocytes. Immunology. 177(2). 398–412.

Nikolaou, Panagiota, et al.. (2025). Empagliflozin restores cardiac metabolism and suppresses immune activation in acute myocardial infarction. Atherosclerosis. 407. 120404–120404. 1 indexed citations

Eleutherakis‐Papaiakovou, Evangelos, Nikolaos Kanellias, Ioannis Ntanasis‐Stathopoulos, et al.. (2025). The Role of the Bone Marrow Microenvironment in Physical Function and Quality of Life in Patients with Multiple Myeloma After First-Line Treatment with Novel Agents and Autologous Transplantation. SHILAP Revista de lepidopterología. 5(2). 21–21.

Terpos, Evangelos, Panagiotis Malandrakis, Ioannis Ntanasis‐Stathopoulos, et al.. (2025). Sustained bone marrow and imaging MRD negativity for 3 years drives discontinuation of maintenance post-ASCT in myeloma. Blood. 145(20). 2353–2360. 5 indexed citations

Papavassiliou, Kostas A., Efthimia K. Basdra, Athanasios G. Papavassiliou, et al.. (2025). Non-Canonical Compartmentalization of DROSHA Protein at the Golgi Apparatus: miRNA Biogenesis-Independent Functionality in Human Cancer Cells of Diverse Tissue Origin. International Journal of Molecular Sciences. 26(19). 9319–9319.

Kostopoulos, Ioannis V., Constantin N. Baxevanis, Anastasios Tentolouris, et al.. (2025). Prognostic Significance of Endocrine-Related Adverse Events in Patients with Melanoma, Non-Small Cell Lung Cancer and Urothelial Cancer After Treatment with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis. Cancers. 17(22). 3675–3675.

Ntanasis‐Stathopoulos, Ioannis, Panagiotis Malandrakis, Efstathios Kastritis, et al.. (2025). Evaluating Minimal Residual Disease Negativity as a Surrogate Endpoint for Treatment Efficacy in Multiple Myeloma: A Meta‐Analysis of Randomized Controlled Trials. American Journal of Hematology. 100(3). 427–438. 8 indexed citations

Georgakilas, Alexandros G., et al.. (2024). DExplore: An Online Tool for Detecting Differentially Expressed Genes from mRNA Microarray Experiments. Biology. 13(5). 351–351. 1 indexed citations

10.

Malandrakis, Panagiotis, Ioannis V. Kostopoulos, Despina Fotiou, et al.. (2024). Sustained MRD Negativity for Three Years Can Guide Discontinuation of Lenalidomide Maintenance after ASCT in Multiple Myeloma: Results from a Prospective Cohort Study. Blood. 144(Supplement 1). 361–361. 2 indexed citations

11.

Velentzas, Athanassios D., et al.. (2024). TRBP2, a Major Component of the RNAi Machinery, Is Subjected to Cell Cycle-Dependent Regulation in Human Cancer Cells of Diverse Tissue Origin. Cancers. 16(21). 3701–3701. 2 indexed citations

12.

Stergiou, Ioanna Ε., et al.. (2023). EPH/Ephrin Signaling in Normal Hematopoiesis and Hematologic Malignancies: Deciphering Their Intricate Role and Unraveling Possible New Therapeutic Targets. Cancers. 15(15). 3963–3963. 3 indexed citations

13.

Drosos, Yiannis, Eumorphia G. Konstantakou, S. Markaki, et al.. (2023). Microtubule Dynamics Deregulation Induces Apoptosis in Human Urothelial Bladder Cancer Cells via a p53-Independent Pathway. Cancers. 15(14). 3730–3730. 4 indexed citations

14.

Tsoumani, Maria, Anastasios D. Georgoulis, Panagiota Nikolaou, et al.. (2021). Acute administration of the olive constituent, oleuropein, combined with ischemic postconditioning increases myocardial protection by modulating oxidative defense. Free Radical Biology and Medicine. 166. 18–32. 22 indexed citations

15.

Politou, Marianna, Ioannis V. Kostopoulos, Ioannis Ntanasis‐Stathopoulos, et al.. (2020). Peripheral Blood Immune Profiling of Convalescent Plasma Donors Reveals Alterations in Specific Immune Subpopulations Even at 2 Months Post SARS-CoV-2 Infection. Viruses. 13(1). 26–26. 28 indexed citations

16.

Kostopoulos, Ioannis V., et al.. (2020). Cytotoxicity and Anti-cancer Activity of the Genus Achillea L.. Current Medicinal Chemistry. 27(41). 6910–6925. 7 indexed citations

17.

Benaki, Dimitra, Athanassios D. Velentzas, Ourania Tsitsilonis, et al.. (2020). Malignancy Grade-Dependent Mapping of Metabolic Landscapes in Human Urothelial Bladder Cancer: Identification of Novel, Diagnostic, and Druggable Biomarkers. International Journal of Molecular Sciences. 21(5). 1892–1892. 8 indexed citations

18.

Kalbacher, Hubert, et al.. (2019). In Vitro Immunodetection of Prothymosin Alpha in Normal and Pathological Conditions. Current Medicinal Chemistry. 27(29). 4840–4854. 4 indexed citations

19.

Terpos, Evangelos, Ioannis V. Kostopoulos, Ioannis Ntanasis‐Stathopoulos, et al.. (2017). Next Generation Flow (NGF) Cytometry for Minimal Residual Disease (MRD) Evaluation in Multiple Myeloma (MM) Patients with Sustained Complete Response (CR) after Frontline Therapy: Results of a Prospective Single-Center Analysis. Blood. 130. 3088–3088. 3 indexed citations

20.

Baxevanis, Constantin N., et al.. (2002). HER‐2/neu–derived peptide epitopes are also recognized by cytotoxic CD3⁺CD56⁺ (natural killer T) lymphocytes. International Journal of Cancer. 98(6). 864–872. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact